Postdoctoral Fellow Position Now Open
The Boulis laboratory is seeking a capable and self-motivated individual to oversee projects involving the development of lentiviral vector-induced glioblastoma models in the brain of a large animal (swine). The candidate should hold a Ph.D. in the appropriate field and have a strong background in neuro-oncology and related areas. The ideal candidate should also have previous understanding and experience in gene therapy/vectorology and molecular biology. Email to apply.
'It's a Little Bit Like Living on Mars': Inside a COVID-19 ICU
CNN Chief Medical Correspondent Dr. Sanjay Gupta talks to his longtime friend and colleague Dr. Nick Boulis about what was it was like to work inside Emory University's Covid-19 intensive care unit and watch the deadly power of this disease firsthand.
Genetic Doppelgänger: Emory Research Provides Insight into Two Neurological Puzzles
An international team led by Emory scientists has gained insight into the pathological mechanisms behind two devastating neurodegenerative diseases. The scientists compared the most common inherited form of amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD) with a rarer disease called spinocerebellar ataxia type 36 (SCA36).
Coda Biotherapeutics is Developing a Cure for Pain
Co-founded by researchers Joseph Glorioso, from the University of Pittsburgh’s microbiology and molecular genetics department, and Dr. Nicholas Boulis, the founder of Emory’s Gene and Cell Therapy for Neurorestoration Laboratory, Coda uses gene therapies to treat neurological diseases starting with severe pain and epilepsy.
Renew Biopharma appoints Dr. Nicholas Boulis to Scientific Advisory Board
Dr. Nicholas Boulis was appointed to a member of the Renew Biopharma Scientific Advisory Board by CEO Michael Mendez.
65+ Spine Surgeons on the Forefront of Biologics and Stem Cells
Dr. Boulis was among the physicians who performed the first FDA-approved stem cell injection into a patient's cervical spine for amyotrophic lateral sclerosis treatment. The four-hour operation included five cervical spine injections containing more than 500,000 stem cells total. Dr. Boulis' research interests include biological neurorestoration and neuromodulation through cell, protein and gene delivery to the nervous system.